U.S. Patent Disclosures
Thursday, February 7, 2013
• Celladon Corp., of San Diego, was issued a notice of allowance for U.S. Patent application No. 13/145,787, "Fluorescence resonance energy transfer assays for sarco/endoplasmic reticulum calcium ATPase and phosphlamban."
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.